Meg Jardine's Publications

• Renal trials in diabetes need a platform: time for a global approach?

  Journal articles

  2018

  The Lancet Diabetes and Endocrinology

• Design and methods of the REMOVAL-HD study: A tRial Evaluating Mid cut-Off Value membrane clearance of Albumin and Light chains in HaemoDialysis patients

  Journal articles

  2018

  BMC Nephrology

• Burden of Care and Quality of Life Among Caregivers for Adults Receiving Maintenance Dialysis: A Systematic Review

  Journal articles

  2018

  American Journal of Kidney Diseases

• Cardiovascular and renal outcomes with canagliflozin according to baseline kidney function data from the CANVAS program

  Journal articles

  2018

  Circulation

• The canagliflozin and renal endpoints in diabetes with established nephropathy clinical evaluation (CREDENCE) study rationale, design, and baseline characteristics

  Journal articles

  2018

  American Journal of Nephrology

• THE QUALITY OF LIFE IMPROVEMENTS ASSOCIATED WITH EXTENDED HOURS DIALYSIS ARE CONSISTENT ACROSS SUBGROUPS

  Conference Abstracts

  2018

  NEPHROLOGY

• Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

  Journal articles

  2017

  The Lancet

• Action plan for optimizing the design of clinical trials in chronic kidney disease

  Journal articles

  2017

  Kidney International Supplements

• Closing the gap between evidence and practice in chronic kidney disease

  Journal articles

  2017

  Kidney International Supplements

• ENDOVASCULAR EVENTS, HEART FAILURE AND SURVIVAL IN DIALYSIS PATIENTS

  Conference Papers

  2017

  NEPHROLOGY

• Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis

  Journal articles

  2017

  PLoS ONE

• Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: The TESTING randomized clinical trial

  Journal articles

  2017

  JAMA - Journal of the American Medical Association

• A trial of extending hemodialysis hours and quality of life

  Journal articles

  2017

  Journal of the American Society of Nephrology

• Scoring Risk Scores: Considerations Before Incorporating Clinical Risk Prediction Tools Into Your Practice

  Journal articles

  2017

  American Journal of Kidney Diseases

• Identifying and integrating patient and caregiver perspectives for clinical practice guidelines on the screening and management of infectious microorganisms in hemodialysis units

  Journal articles

  2017

  Hemodialysis International

• Muscle strength, mobility, quality of life and falls in patients on maintenance haemodialysis: A prospective study

  Journal articles

  2017

  Nephrology

• Erythropoietic response to oral iron in patients with nondialysis-dependent chronic kidney disease in the FIND-CKD trial

  Journal articles

  2017

  Clinical Nephrology

• Canagliflozin slows progression of renal function decline independently of glycemic effects

  Journal articles

  2017

  Journal of the American Society of Nephrology

• We need to talk about depression and dialysis: But what questions should we ask, and does anyone know the answers?

  Journal articles

  2017

  Clinical Journal of the American Society of Nephrology

• Management of patients with diabetes and CKD:conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

  Journal articles

  2016

  Kidney International

• Canagliflozin slows progression of renal function decline independent of glycaemic effects

  Conference Papers

  2016

  DIABETOLOGIA

• Challenges in conducting clinical trials in nephrology: conclusions from a Kidney DiseaseImproving Global Outcomes (KDIGO) Controversies Conference

  Conference Papers

  2016

  Kidney International

• THE OXFORD CLASSIFICATION SYSTEM (MEST) IN IGA NEPHROPATHY (IGAN): READY FOR ROUTINE CLINICAL PRACTICE?

  Conference Papers

  2016

  NEPHROLOGY

• TRENDS IN THE RELATIVE SURVIVAL OF MIDDLE AGED AND OLDER PEOPLE ON DIALYSIS IN AUSTRALIA

  Conference Papers

  2016

  NEPHROLOGY

• TRENDS IN HAEMOGLOBIN CONCENTRATION AND ERYTHROPOIESIS STIMULATING AGENT (ESA) USE IN THE AUSTRALIAN DIALYSIS POPULATION

  Conference Papers

  2016

  NEPHROLOGY

• IS IMMUNOSUPPRESSIVE THERAPY BENEFICIAL FOR IDIOPATHIC MEMBRANOUS NEPHROPATHY: A SYSTEMATIC REVIEW AND TRIAL SEQUENTIAL ANALYSIS OF PUBLISHED TRIALS

  Conference Papers

  2016

  NEPHROLOGY